ORKEDIA® (evocalcet) is a new type of oral calcimimetics agent. The drug suppresses parathyroid hormone secretion by acting on calcium receptors on parathyroid gland cells.
This page features main products from Kyowa Kirin worldwide portfolio and may not be available in all countries or regions, or may be approved for different indications, in different dosages, or in different strengths. In general, those products are available only by prescription through local healthcare professionals.
Please visit our local country or region website for local information: